On ECHEMI
Home > Drugs > Luan Worldbest Pharmaceuticals Co., Ltd.
Luan Worldbest Pharmaceuticals Co., Ltd.
  • Founded in:

    1998-06-01
  • Country:

    China China
  • Address:

    The intersection of Gaocheng East Road and Jingliu Road, Economic and Technological Development Zone, Lu'an City, Anhui Province
  • Tax NO.:

    91340000152947607T
  • Registered Funds:

    200 million yuan
  • Email:

Related Drugs
Glucose and Sodium Chloride Injection
This product is a compound preparation containing glucose and sodium chloride.
Name Description Content CAS NO. Registered Holders
GLUCOSE

Glucose is one of the main sources of calories for the human body

More

Glucose is one of the main sources of calories for the human body

58367-01-4 14
Sodium chloride

Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid in the human body.

More

Sodium and chloride are important electrolytes in the body, mainly present in extracellular fluid, and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid in the human body.

7647-14-5 42
Dextran 40 Sodium Chloride Injection
This product is a sterile aqueous solution of dextran 40 and 0.9% sodium chloride. Dextran 40 is a high molecular weight glucose polymer produced by fermentation of sucrose, with an average molecular weight of 40,000.
Name Description Content CAS NO. Registered Holders
SodiumChloride(0.9%)

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect.

More

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect.

0
Dextran

It is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and more short-lived than dextran 70, but its microcirculation improvement effect is stronger than dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. It has an osmotic diuretic effect.

More

It is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and more short-lived than dextran 70, but its microcirculation improvement effect is stronger than dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. It has an osmotic diuretic effect.

9004-54-0 16
Sodium chloride

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect.

More

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water to increase blood volume, and increase and maintain blood pressure. Its blood volume expansion effect is weaker and shorter than that of dextran 70, but its effect on improving microcirculation is stronger than that of dextran 70. It can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis. In addition, it also has an osmotic diuretic effect.

0.9% 7647-14-5 42
SodiumChloride(0.9%)

Used as a solvent, it participates in maintaining osmotic pressure balance and has an osmotic diuretic effect.

More

Used as a solvent, it participates in maintaining osmotic pressure balance and has an osmotic diuretic effect.

0
Dextran 40 Glucose Injection
This product is a sterile aqueous solution of dextran 40 and 5% glucose. Its average molecular weight is 40,000.
Name Description Content CAS NO. Registered Holders
Dextran

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water to increase blood volume, and increase and maintain blood pressure; it can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis; it has an osmotic diuretic effect.

More

This product is a blood volume expander. After intravenous injection, it can increase plasma colloidal osmotic pressure, absorb extravascular water to increase blood volume, and increase and maintain blood pressure; it can disaggregate aggregated red blood cells and platelets, reduce blood viscosity, improve microcirculation, and prevent thrombosis; it has an osmotic diuretic effect.

9004-54-0 16
GLUCOSE

It acts as a solvent and energy supplement, and also assists dextran 40 in exerting its medicinal effects.

More

It acts as a solvent and energy supplement, and also assists dextran 40 in exerting its medicinal effects.

5% 58367-01-4 14
Mannitol injection
The main ingredient of this product and its chemical name: D-mannitol.
Name Description Content CAS NO. Registered Holders
D-Mannitol

Mannitol injection is a hypertonic preparation that produces direct pharmacological effects through hypertonic dehydration, eliminating brain edema and reducing intracranial pressure. 1g of mannitol can produce an osmotic concentration of 5.5mOsm. Injection of 100g of mannitol can transfer 2000ml of intracellular water to the extracellular space and excrete 50g of urinary sodium. Tissue dehydration effect: Increases plasma osmotic pressure, causing water in tissues (including eyes, brain, cerebrospinal fluid, etc.) to enter blood vessels, thereby reducing tissue edema, reducing intraocular pressure, intracranial pressure, and cerebrospinal fluid volume and pressure. Diuretic effect: Increases blood volume, promotes prostaglandin I2 secretion, dilates renal blood vessels, increases renal blood flow, reduces tubular reabsorption of water and electrolytes, increases tubular fluid flow, and accelerates the excretion of certain drugs and poisons.

More

Mannitol injection is a hypertonic preparation that produces direct pharmacological effects through hypertonic dehydration, eliminating brain edema and reducing intracranial pressure. 1g of mannitol can produce an osmotic concentration of 5.5mOsm. Injection of 100g of mannitol can transfer 2000ml of intracellular water to the extracellular space and excrete 50g of urinary sodium. Tissue dehydration effect: Increases plasma osmotic pressure, causing water in tissues (including eyes, brain, cerebrospinal fluid, etc.) to enter blood vessels, thereby reducing tissue edema, reducing intraocular pressure, intracranial pressure, and cerebrospinal fluid volume and pressure. Diuretic effect: Increases blood volume, promotes prostaglandin I2 secretion, dilates renal blood vessels, increases renal blood flow, reduces tubular reabsorption of water and electrolytes, increases tubular fluid flow, and accelerates the excretion of certain drugs and poisons.

69-65-8 3
Nikethamide
Name Description Content CAS NO. Registered Holders
N,N-DIETHYLNICOTINAMIDE

Extract from the above information

More

Extract from the above information

59-26-7 9
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.